sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Real World Evidence Solutions Market, by Therapeutic Area (Cardiovascular, Oncology, Immunology), by Component (Dataset and Services), by End-User (Medical Devices, Payers, Pharmaceuticals, Providers), by Regional Outlook (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) - Market Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2015-2023

Global Real World Evidence Solutions Market, by Therapeutic Area (Cardiovascular,...

Home / Categories / Healthcare
Global Real World Evidence Solutions Market, by Therapeutic Area (Cardiovascular, Oncology, Immunology), by Component (Dataset and Services), by End-User (Medical Devices, Payers, Pharmaceuticals, Providers), by Regional Outlook (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) - Market Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2015-2023
Global Real World Evidence Solutions...
Report Code
RO1/117/1012

Publish Date
05/Oct/2019

Pages
125
PRICE
$ 5150/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 8000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
3. Executive Summary
4. Industry Insights
4.1. Industry Impact and Forces
4.1.1. Growth Drivers
4.1.2. Challenges
4.1.3. Trends
4.2. Technology Landscape
4.3. Regulatory Framework
4.4. Company Share Analysis, 2018
4.5. Growth potential Analysis
4.6. Strategic Outlook
4.7. Porter's analysis
4.8. PESTEL analysis
5. Global Real World Evidence Solutions Market Overview
5.1. Market Size & Forecast
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Therapeutic Area
5.2.1.1. Cardiovascular
5.2.1.2. Oncology
5.2.1.3. Immunology
5.2.2. By Component
5.2.2.1. Dataset
5.2.2.2. Services
5.2.3. By End-User
5.2.3.1. Medical Devices
5.2.3.2. Payers
5.2.3.3. Pharmaceuticals
5.2.3.4. Providers
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia Pacific
5.2.4.4. South America
5.2.4.5. Middle East & Africa
6. North America Real World Evidence Solutions Market Overview
6.1. Market Size & Forecast, 2015-2025
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Therapeutic Area
6.2.2. By Component
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
7. Europe Real World Evidence Solutions Market Overview
7.1. Market Size & Forecast, 2015-2025
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Therapeutic Area
7.2.2. By Component
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Spain
8. Asia Pacific Real World Evidence Solutions Market Overview
8.1. Market Size & Forecast, 2015-2025
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Therapeutic Area
8.2.2. By Component
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Southeast Asia
9. Latin America Real World Evidence Solutions Market Overview
9.1. Market Size & Forecast, 2015-2025
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Therapeutic Area
9.2.2. By Component
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
10. Middle East & Africa Real World Evidence Solutions Market Overview
10.1. Market Size & Forecast, 2015-2025
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Component
10.2.3. By End-User
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, SWOT Analysis and Strategic Outlook)
11.1. SAS
11.2. Syneos Health
11.3. Anthem
11.4. Clinigen Group
11.5. Palantir Technologies
11.6. Flatiron Health
11.7. IQVIA
11.8. ICON
11.9. PAREXEL
11.10. Pharmaceutical Product Development
11.11. Optum
11.12. International Business Machines Corporation
11.13. Cognizant
11.14. Oracle
11.15. Other Prominent Players
*Financial Details Not Be Captured in Case of Unlisted Companies
The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com